The embargo on all abstracts part of the 2018 Genitourinary Cancers Symposium lifted at 5:00 p.m. ET on Monday, February 5, 2018.
- 2018 Symposium Highlights Notable Research Advances in Genitourinary Cancers
SAN FRANCISCO - Eight noteworthy studies exploring key research in the treatment of genitourinary cancers will be presented at the 2018 Genitourinary Cancers Symposium, taking place February 8-10 at the Moscone West Building in San Francisco, California. Read the full release.
- Adding Immunotherapy to Standard Treatment Slows Growth of Advanced Kidney Cancer, With Fewer Side Effects
ALEXANDRIA, Va. – In a phase III clinical trial of people with previously untreated metastatic renal cell cancer (mRCC), combining immunotherapy atezolizumab with targeted therapy bevacizumab delayed cancer growth by about three months longer than sunitinib, another targeted therapy. Read the full release.
- New Model Predicts Survival for People With Bladder Cancer Receiving Immunotherapy
ALEXANDRIA, Va. – Researchers have developed a model to predict overall survival for people with advanced urothelial cancers treated with the immune checkpoint inhibitor atezolizumab. Read the full release.
- Chemotherapy Added to Hormone Therapy for Prostate Cancer Improves Quality of Life
ALEXANDRIA, Va. – A new analysis of the ongoing STAMPEDE clinical trial found that adding the chemotherapy drug docetaxel to hormone therapy for advanced prostate cancer improves quality of life and lowers the need for subsequent therapy. Docetaxel was also found to be cost-effective. Read the full release.
- Apalutamide Delays Prostate Cancer Metastases by More Than Two Years
ALEXANDRIA, Va. – Findings from the phase III placebo-controlled SPARTAN trial suggest that apalutamide is an effective treatment for men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk for developing metastatic disease, and for whom no approved treatments exist. Read the full release.
- Upcoming Symposium to Feature New Insights for Management of Prostate, Bladder, Kidney Cancers
ALEXANDRIA, Va. – Co-sponsors of the 2018 Genitourinary Cancers Symposium announced today four abstracts to be highlighted in the meeting’s official Press Program. Researchers will present the findings of these studies in an embargoed presscast for reporters, taking place Monday, February 5, 2018, from 12:00 noon – 1:30 p.m. ET. Read the full release.
Watch the Presscast Recording
View a recording of the February 5 presscast, featuring four studies from the 2018 Genitourinary Cancers Symposium
Meet the News Planning Team
- Sumanta Kumar Pal, MD
City of Hope Comprehensive Cancer Center
American Society of Clinical Oncology
- Daniel A. Hamstra, MD, PhD
William Beaumont Oakland University Medical School and Beaumont Health
American Society for Radiation Oncology
- Katie Murray, DO
University of Missouri
Society of Urologic Oncology
- Meeting program
- View all abstracts
- View abstracts by track:
- Meeting Videos and Slides (Members of the media receive complimentary access. For login details, please contact the Media Team.)
2017 Genitourinary Cancers Symposium:
- 2017 Symposium Highlights Notable Research Advances in Genitourinary Cancers
ORLANDO – Five studies exploring key issues in the treatment of genitourinary cancers will be presented at the 2017 Genitourinary Cancers Symposium, taking place February 16-18 at Rosen Shingle Creek in Orlando, Florida. Read the full release.
- In Advanced Kidney Cancer, Antibiotic Use Lowers Efficacy of Immunotherapy
ALEXANDRIA, Va. – A new retrospective analysis suggests that immunotherapy may be less effective in patients who receive antibiotics less than a month before starting treatment. Read the full release.
- Some Patients Experience Long-Term Tumor Control Even After Stopping Immunotherapy Early
ALEXANDRIA, Va. – Early findings from a new study appear to challenge the current standard practice for immune checkpoint inhibitor therapy – continuing treatment until cancer worsens. Read the full release.
- Blood Test Uncovers Potential New Treatment Targets in Advanced Prostate Cancer
ALEXANDRIA, Va. – Analysis of free-floating cancer DNA from blood samples has yielded leads for new prostate cancer treatment targets. Read the full release.
- 2017 Genitourinary Cancers Symposium Press Program to Feature Research Advances in Prostate, Urothelial, Kidney Cancers
ALEXANDRIA, Va. – Co-sponsors of the 2017 Genitourinary Cancers Symposium announced today three abstracts to be highlighted in the meeting’s official Press Program. Read the full release.
- View a recording of the February 13 presscast, featuring three studies from the 2017 Genitourinary Cancers Symposium